Attached files
file | filename |
---|---|
EX-32.2 - EX-32.2 - Replimune Group, Inc. | a19-26434_3ex32d2.htm |
EX-31.2 - EX-31.2 - Replimune Group, Inc. | a19-26434_3ex31d2.htm |
EX-31.1 - EX-31.1 - Replimune Group, Inc. | a19-26434_3ex31d1.htm |
EX-10.2 - EX-10.2 - Replimune Group, Inc. | a19-26434_3ex10d2.htm |
10-Q - 10-Q - Replimune Group, Inc. | a19-26434_310q.htm |
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Replimune Group, Inc. (the Company) for the period ended December 31, 2019, as filed with the Securities and Exchange Commission on the date hereof (the Report), the undersigned, Philip Astley-Sparke, Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:
(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: February 13, 2020 |
By: |
/s/ Philip Astley-Sparke |
|
|
Philip Astley-Sparke |
|
|
Chief Executive Officer |
|
|
(Principal Executive Officer) |